Current Roles

Employees:
102
Revenue:
$29.4M
About
Cara Therapeutics is an emerging biotechnology company focused on developing novel therapeutics to treat pain, inflammation and pruritus. Cara possesses both near-term clinical development opportunities combined with proprietary approaches to developing first-in-class novel therapeutics. Cara's most advanced patented compound, CR845, is currently undergoing clinical testing for acute pain and uremic pruritus. This compound possesses analgesic, anti-inflammatory and antipruritic activities appropriate for multiple therapeutic applications. In addition, Cara aims to develop a future pipeline of first-in-class molecules at novel analgesic and anti-inflammatory targets using its proprietary drug screening technology.
Cara Therapeutics Address
107 Elm Street
Stamford, null
United States
Cara Therapeutics Email

Past Companies

Cara TherapeuticsVice President
Axovant SciencesVice President
Purdue Pharma L.P.Director, Clinical Research

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.